Topic Hub
15 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 15 of 15 clinical reviews.
Specific food choices, meal timing, hydration targets, and lifestyle adjustments that reduce dizziness caused by oral micronized progesterone's GABAergic sedative effects. Clinically actionable guidance for patients and prescribers.
Read clinical reviewHow common is dizziness on oral micronized progesterone, how bad does it get, and what actually makes it better? Evidence-anchored answers for patients and prescribers managing it right now.
Read clinical reviewA week-by-week clinical timeline of dizziness caused by oral micronized progesterone, including the allopregnanolone mechanism, trial data on incidence and duration, and practical management steps for patients and prescribers.
Read clinical reviewEvidence-based dietary strategies to reduce dizziness caused by oral micronized progesterone (Prometrium). Covers meal timing, specific nutrients, hydration, and food-drug interactions backed by clinical data.
Read clinical reviewA step-by-step clinical protocol for assessing and managing dizziness caused by oral micronized progesterone, covering GABAergic mechanism, dose timing, escalation criteria, and when to consider discontinuation.
Read clinical reviewA clinical guide to OTC and prescription options for managing progesterone-induced dizziness, including dose ranges, timing strategies, and drug interactions to avoid.
Read clinical reviewLearn when dizziness from oral micronized progesterone (Prometrium) requires medical attention, why it happens through allopregnanolone's GABAergic activity, and how to manage it safely.
Read clinical reviewPersistent dizziness on oral micronized progesterone (Prometrium) may signal excessive GABAergic activity from allopregnanolone. Learn why it happens, when it resolves, and evidence-based strategies when it doesn't.
Read clinical reviewDizziness from oral micronized progesterone is caused by its GABAergic metabolite allopregnanolone. Learn why it happens, how to manage it, and which progestogen alternatives avoid this side effect.
Read clinical reviewA clinician-reviewed severity grading rubric for dizziness caused by oral micronized progesterone, covering mechanism, dose relationships, management strategies, and when to escalate care.
Read clinical reviewEvidence-based supplements and strategies to manage dizziness caused by oral micronized progesterone (Prometrium), including magnesium, vitamin B6, ginger, and timing adjustments.
Read clinical reviewStep-by-step titration protocols for managing dizziness caused by oral micronized progesterone's GABAergic activity, including when to slow, pause, step down, or microdose.
Read clinical reviewA clinical guide to the severity criteria, quality-of-life thresholds, and switching strategies that determine when dizziness on oral micronized progesterone warrants discontinuation rather than adjustment.
Read clinical reviewOral micronized progesterone causes dizziness through its metabolite allopregnanolone, a potent GABA-A receptor modulator. Learn the neuropharmacology, risk factors, timing, and evidence-based strategies to reduce this common side effect.
Read clinical reviewOral micronized progesterone is converted to allopregnanolone in the gut and liver. Allopregnanolone potentiates GABA-A receptors, producing CNS sedation and vestibular suppression that patients experience as dizziness. This page explains the full pharmacological pathway and what to do about it.
Read clinical review